Delivery Order SPE2DX15D2013-SPE2DX24F30E4

Award Date 2/22/24
Potential Completion Date 2/23/24
Potential Value $4.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $5,124.67 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to provide BRIVIACT 50 MG TABLET 60S, a pharmaceutical product. This delivery order has a completion date of February 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide BRIVIACT 75 MG TABLET 60S, a pharmaceutical product. The contract has a potential value of $1,080.65 and a performance period through February 14, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the sole...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The $5,115.84 contract is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, with a performance period through August 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 for providing a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $2,218.79 to Amerisourcebergen Drug Corp, the prime contractor. The contract is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, with a completion date of February 21, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. and operates as a for-profit organization. This delivery order contract is part of a larger...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $2,579.19 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the provision of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product, with a completion date of February 15, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, provides the Defense Logistics Agency (DLA) with the delivery of BRIVIACT 100 MG TABLET 60S for a ceiling value of $2,557.92. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 19, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a firm fixed price delivery order contract (SPE2DX15D6039|SPE2DX24FSBYN) by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 4563920197 BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $5,115.84 and a performance period through March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract, which does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,318.95 firm fixed-price delivery order is for the supply of BRIVIACT 75 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a global pharmaceutical distribution company, to provide BRIVIACT 100 MG TABLET 60S. The potential value of this contract is $2,382.26, with a completion date of March 5, 2024. Amerisourcebergen Drug Corp is a for-profit organization that serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,979.24 Firm Fixed Price Delivery Order is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of October 17, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DX15D2013
    Indefinite Delivery Contract
  • SPE2DX15D2013-SPE2DX24F30E4
    Delivery Order

Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $4,205.24 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to supply 60 tablets of BRIVIACT 100 MG. This delivery order falls under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide. The IDC, valued at up to $999,999,999.00, does not have a set-aside designation and was awarded solely to Amerisourcebergen Drug Corp as a single award contract.

Generated 5/23/24, 9:35 AM